Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China · Delayed Price · Currency is CNY

53.23

-0.71 (-1.32%)

At close: Feb 26, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Respiratory Products	177.35M	164.41M	303.85M	292.31M	249.90M
Respiratory Products Growth	7.87%	-45.89%	3.95%	16.97%	152.00%
Total	177.35M	164.41M	303.85M	292.31M	249.90M
Total Growth	7.87%	-45.89%	3.95%	16.97%	152.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	177.35M	164.41M	303.85M	292.31M	249.90M
China Growth	7.87%	-45.89%	3.95%	16.97%	152.00%
Total	177.35M	164.41M	303.85M	292.31M	249.90M
Total Growth	7.87%	-45.89%	3.95%	16.97%	152.00%

Source: S&P Global Market Intelligence.